Use of Autoantigen-Loaded Phosphatidylserine-Liposomes to Arrest Autoimmunity in Type 1 Diabetes

• Irma Pujol-Autonell,

  Affiliation Immunology Department, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain

  ⨯
• Arnau Serracant-Prat,

  Affiliation Immunology Department, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain

  ⨯
• Mary Cano-Sarabia,

  Affiliation Catalan Institute of Nanoscience and Nanotechnology, Bellaterra, Spain

  ⨯
• Rosa M. Ampudia,

  Affiliation Immunology Department, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain

  ⨯
• Silvia Rodriguez-Fernandez,

  Affiliation Immunology Department, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain

  ⨯
• Alex Sanchez,

  Affiliation Statistics Department, Faculty of Biology, University of Barcelona, Barcelona, Spain

  ⨯
• Cristina Izquierdo,

  Affiliation Department of Physiology and Immunology, Faculty of Biology, University of Barcelona, Barcelona, Spain

  ⨯
• Thomas Stratmann,

  Affiliation Department of Physiology and Immunology, Faculty of Biology, University of Barcelona, Barcelona, Spain

  ⨯
• Manuel Puig-Domingo,

  Affiliation Endocrinology and Nutrition Service, Hospital Germans Trias i Pujol, Badalona, Spain

  ⨯
• Daniel Maspoch,

  Affiliations Catalan Institute of Nanoscience and Nanotechnology, Bellaterra, Spain, Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

  ⨯
• Joan Verdaguer,

  Affiliation Immunology Unit, Department of Experimental Medicine, University of Lleida and IRBLleida, Lleida, Spain

  ⨯
• Marta Vives-Pi

  * E-mail: mvives@igtp.cat

  Affiliation Immunology Department, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain

  ⨯